Description: BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
Home Page: www.bioton.pl
ul. Poznanska 12
Ozarów Mazowiecki,
05-850
Poland
Phone:
48 22 721 4000
Officers
| Name | Title |
|---|---|
| Mr. Jeremy Launders | CEO & President of the Management Board |
| Mr. Adam Tomasz Polonek | Member of Management Board |
| Ms. Anna Grabowska | Senior Finance Manager |
| Mr. Michal Deptuch | Operations Director |
| Renata Prokopczyk | Chief Accountant |
| Ms. Kamila Musnicka | Director of Legal Department |
| Mr. Mateusz Patryk Kosecki | Head of Biolek Business Unit & CEO of Biolek Sp. Z O.O. |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4436 |
| Price-to-Sales TTM: | 0.3567 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 355 |